Ocular Surface Review
OSD Management in Glaucoma Patients
How to minimize the use of drops while treating both conditions.
08/15/2024
As Smooth As Silk
This unique protein is a brand new DED treatment.
05/15/2024
Shining the Slit Lamp on ADCs
ODs can greatly help ovarian cancer patients who are taking this advanced therapeutic agent, specifically Elahere.
03/15/2024
Not So Benign OSD
If your patient isn’t responding to treatment, look beyond the typical forms of ocular surface disease.
11/15/2023
Call the Exterminator
A new eye drop, Xdemvy, shows positive results in wiping out the unusually common condition known as Demodex blepharitis.
09/15/2023
First of its Kind
Miebo now gives us a medication option that targets MGD and evaporative DED.
07/15/2023
Drink Up
Hydrating the whole body—not just the eyes—is key to improving the ocular surface.
05/15/2023
Toxic Work Environment
Be aware of certain glaucoma therapy options that could harm the ocular surface.
03/15/2023
Right Tool for the Job
These small but mighty instruments can help you better perform a number of procedures and will enhance your practice.
02/15/2023
Making the Grade
Studies show promising results for CyclASol, a new medication to treat DED that could be approved next year.
11/15/2022
Upcoming Events
December 5, 2024
Rethinking Dry Eye Disease: A Contemporary Approach to a Complex Condition
Location: Virtual
Presenters: Nate Lighthizer, OD, and Dagny Zhu, MD
Webinar: 9:00pm ET
Sponsored by Bausch + Lomb
December 6-7, 2024
December 7-8, 2024
Retina Update 2024
Location: Westin Carlsbad, Carlsbad, California
Program Chairs: Mohammad Rafieetary, OD, and Steven Ferrucci, OD
Earn up to 11 LIVE COPE credits (accreditation pending)
